Changyu Wang
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 9
- Immunology top 1%
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 4
-
- Ferroptosis and cancer prognosis 4
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 5
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 12
-
- Ovarian cancer diagnosis and treatment 18
-
- RNA modifications and cancer 5
- Co-authors
- Alan J. KormanMark SelbyLieping ChenJohn D. PowderlyElizabeth StankevichJulie R. BrahmerTheresa M. SalayMarta M. Gilson
- Journals
- International Journal of Radiation Oncology*Biology*Physics (6 papers)Journal of Clinical Oncology (5 papers)Agronomy (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Changyu Wang
76 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 3.1k
- Immunology 1.9k
- Pulmonary and Respiratory Medicine 845
- Cancer Research 383
- Obstetrics and Gynecology 182
Countries citing papers authored by Changyu Wang
This map shows the geographic impact of Changyu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyu Wang more than expected).
Fields of papers citing papers by Changyu Wang
This network shows the impact of papers produced by Changyu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyu Wang. The network helps show where Changyu Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Changyu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 17 | |
| 7 | 2023 | 21 | |
| 8 | 2023 | 31 | |
| 9 | 2023 | 3 | |
| 10 | In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primatesbreakdown → | 2014 | 472 |
| 11 | 2013 | 45 | |
| 12 | 2012 | 14 | |
| 13 | 2012 | 15 | |
| 14 | 2012 | 33 | |
| 15 | 2010 | 15 | |
| 16 | 2010 | 3 | |
| 17 | 2009 | 153 | |
| 18 | 2007 | 40 | |
| 19 | 2004 | 2 | |
| 20 | 1996 | 11 |
About Changyu Wang
Changyu Wang is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Cancer Research, Immunology and Oncology, having authored 79 papers that have together received 4.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (18 papers), Endometrial and Cervical Cancer Treatments (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (8 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Immune Cell Function and Interaction (4 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Oncology (3.1k citations), Immunology (1.9k citations), Pulmonary and Respiratory Medicine (845 citations), Cancer Research (383 citations) and Obstetrics and Gynecology (182 citations). Changyu Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Alan J. Korman, Mark Selby, Lieping Chen, John D. Powderly, Elizabeth Stankevich, Julie R. Brahmer, Theresa M. Salay, Marta M. Gilson, Charles G. Drake and Janis M. Taube. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Agronomy, Oncotarget and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.